The present invention is related to a novel process for preparing flurbiprofen orally disintegrating formulations, more specifically the present invention is associated with the decrease of potential side effects of flurbiprofen that may arise in esophagus and stomach by prevention any irritation related to flurbiprofen during its passage through esophagus by ensuring the release of it in stomach.